H-Source Releases Marketplace Platform Software Version 2.5

Press Releases |

VANCOUVER, BRITISH COLUMBIA / December 21, 2015 – H-Source Holdings Ltd. (CSE: HSI) (the “Company” or “H-Source”) is pleased to announce the commercialization of its proprietary hospital-to-hospital marketplace network. H-Source has turned on revenue creation and tracking capabilities built into the marketplace platform for software version 2.5 after successful pilot tracking transactions through the system for its member hospitals.

By the release of software version 2.5, H-Source is focusing more resources on sales and marketing activities to increase support for current members while moving forward implementing the platform to a backlog of newly committed members as well as signing up new hospitals and medical facilities, expanding both inventory listings and member hospitals. As of now, H-Source has more than 40 medical facilities as part of our marketplace network.

“With the release of Version 2.5 of our software platform, we are poised to sign up more medical facilities and expand our marketplace network in the first quarter of 2016,”commented Mr. John Kupice, CEO and Director of H-Source. “We will have a growing network of medical facilities with a common goal to reducing operating costs and medical waste by participating in our network.”

About H-Source Holdings Inc.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and trusted marketplace for member hospitals to buy, sell and transfer excess inventory supplies and capital equipment with each other. Member hospitals can conduct secure transactions within Integrated Delivery Networks, Group Purchasing Organizations, complete H-Source network or customize their own group hospitals using H-Source’s built-in filters. This marketplace network is specifically designed to reduce health care costs and medical product waste. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

“John Kupice”

John Kupice

CEO & Director

For further information, please contact:

John Kupice, CEO and Director

H-Source Holdings Ltd.

Telephone: 1-888-900-4549

Email: jkupice@h-source.com

or

James Beesley

Telephone: 778-389-7715

Email: james@sequoiapartners.ca

CAUTIONARY DISCLAIMER STATEMENT: The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company’s shares on the Canadian Securities Exchange and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the Canadian Securities Exchange and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…